
Eitan Group Launches New Preventative Maintenance Servicing Tool for Sapphire Line of Infusion Pumps
New Tool to Reduce Ownership Costs and Facilitate Manufacturer Documented Certification between Patients Eitan Group to Provide Demonstrations of Service Tool at MEDICA Trade Fair, November 18-21, Düsseldorf, Germany.
Today, most infusion pump certification checks are performed manually, and require the purchase of additional lab materials, such as specified syringes, scales and other equipment.
FasTestPM will replace Q Core’s previous maintenance kit and will allow end-users to quickly and economically conduct full maintenance tests, including occlusion detection, air detection and pump accuracy checks. The pricing for the new tool will be 90% less than the previous kit and will have a total runtime of four minutes, an 83% reduction in runtime from the previous kit, significantly reducing both time and expenses for pump service.
“We are revolutionizing the entire concept of preventive maintenance. With this new tool, our maintenance tests are now automatic, paperless and be performed anywhere, including alternate site providers. This provides the end-user the flexibility and confidence to perform at the highest level,” said Ohad Upin, Sapphire Product Manager for Eitan Group. “By listening to our customers, we can evolve and improve our products and their functionality according to the end-user’s needs, ensuring safer infusion systems.”
Eitan Group will be demonstrating the new service tool along with its other infusion and drug delivery products at the
FasTestPM will officially launch at the
###
About Eitan Group
Eitan Group is focused on infusion therapy and technologies, developing future-ready systems for hospital care and ambulatory settings, as well as wearable solutions for easy self-administration. Eitan Group initially entered the infusion market in 2009, and a decade later, with data on over 18 million liters of infusions completed, now consists of three affiliate companies:
SOURCE: Eitan Group
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.